Alessandro Zuddas
Overview
Explore the profile of Alessandro Zuddas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
2956
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Donno F, Balia C, Boi J, Manchia M, Zuddas A, Carucci S
Front Child Adolesc Psychiatry
. 2025 Jan;
2():1149244.
PMID: 39816872
Several studies suggest that children and adolescents with autism spectrum disorder (ASD) often present deficits in executive functions (EFs). The research on cold EF shows a high heterogeneity across different...
2.
Bulajic M, Zuddas A, Panic N, Jankovic K, Rocchi C, Massidda M, et al.
Obes Surg
. 2024 Aug;
34(9):3551-3552.
PMID: 39145918
No abstract available.
3.
Hage A, Man K, Inglis S, Buitelaar J, Carucci S, Danckaerts M, et al.
J Atten Disord
. 2024 Feb;
28(5):699-707.
PMID: 38389266
Objective: Short-term RCTs have demonstrated that MPH-treatment significantly reduces ADHD-symptoms, but is also associated with adverse events, including sleep problems. However, data on long-term effects of MPH on sleep remain...
4.
Carucci S, Zuddas A, Lampis A, Man K, Balia C, Buitelaar J, et al.
J Atten Disord
. 2024 Feb;
28(5):722-739.
PMID: 38366816
Objective: The short-term safety of methylphenidate (MPH) has been widely demonstrated; however the long-term safety is less clear. The aim of this study was to investigate the safety of MPH...
5.
Santosh P, Sala R, Lievesley K, Singh J, Arango C, Buitelaar J, et al.
BMJ Open
. 2023 Dec;
13(12):e068140.
PMID: 38097236
Objectives: As part of the 'Suicidality: Treatment Occurring in Paediatrics (STOP)' study, we developed and performed psychometric validation of an electronic-clinical-outcome-assessment (eCOA), which included a patient-reported-outcome (ePRO), an observer-rated-outcome (eObsRO)...
6.
Cortese S, Purper-Ouakil D, Apter A, Arango C, Baeza I, Banaschewski T, et al.
Lancet Psychiatry
. 2023 Dec;
11(2):143-154.
PMID: 38071998
Psychopharmacological treatment is an important component of the multimodal intervention approach to treating mental health conditions in children and adolescents. Currently, there are many unmet needs but also opportunities, alongside...
7.
Carnovale C, Battini V, Santoro C, Riccio M, Carucci S, Nobile M, et al.
J Am Acad Child Adolesc Psychiatry
. 2023 Jun;
63(3):313-335.
PMID: 37391174
Objective: To summarize the available evidence on metabolic parameters indicating metabolic adverse effects and risk of metabolic syndrome in children and adolescents treated with antipsychotics, following a pre-specified protocol (PROSPERO...
8.
Bellomo A, Masi G, Vita A, Zuddas A
Riv Psichiatr
. 2023 Jun;
58(3):101-109.
PMID: 37317812
In mental health care, transition refers to the pathway of a young person from a child and adolescent mental health service (CAMHS) to an adult mental health service (AMHS). In...
9.
Cortese S, McGinn K, Hojlund M, Apter A, Arango C, Baeza I, et al.
Neurosci Biobehav Rev
. 2023 Mar;
149:105149.
PMID: 37001575
We aimed to identify promising novel medications for child and adolescent mental health problems. We systematically searched https://clinicaltrials.gov/ and https://www.clinicaltrialsregister.eu/ (from 01/01/2010-08/23/2022) for phase 2 or 3 randomized controlled trials...
10.
Man K, Hage A, Banaschewski T, Inglis S, Buitelaar J, Carucci S, et al.
Lancet Psychiatry
. 2023 Mar;
10(5):323-333.
PMID: 36958362
Background: Methylphenidate is the most frequently prescribed medication for the treatment of ADHD in children and adolescents in many countries. Although many randomised controlled trials support short-term efficacy, tolerability, and...